HIRU Stock Overview
Hiru Corporation, through its subsidiary, produces Chinese herbs for the naturopathic industry in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Hiru Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0006 |
52 Week High | US$0.006 |
52 Week Low | US$0.0003 |
Beta | 0 |
1 Month Change | 20.00% |
3 Month Change | -25.00% |
1 Year Change | -68.42% |
3 Year Change | -90.32% |
5 Year Change | 100.00% |
Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
HIRU | US Personal Products | US Market | |
---|---|---|---|
7D | 0% | 4.1% | 1.2% |
1Y | -68.4% | -26.0% | 24.9% |
Return vs Industry: HIRU underperformed the US Personal Products industry which returned -25.4% over the past year.
Return vs Market: HIRU underperformed the US Market which returned 24.7% over the past year.
Price Volatility
HIRU volatility | |
---|---|
HIRU Average Weekly Movement | 37.0% |
Personal Products Industry Average Movement | 8.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HIRU's share price has been volatile over the past 3 months.
Volatility Over Time: HIRU's weekly volatility has increased from 30% to 37% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | www.waterandiceshop.com |
Hiru Corporation, through its subsidiary, produces Chinese herbs for the naturopathic industry in China. It manufactures herbal supplements containing ginseng. The company sells and distributes pharmaceuticals, health and beauty products, dietary and herbal supplements, and other healthcare products.
Hiru Corporation Fundamentals Summary
HIRU fundamental statistics | |
---|---|
Market cap | US$2.07m |
Earnings (TTM) | US$2.95m |
Revenue (TTM) | US$24.04m |
0.0x
P/E Ratio0.0x
P/S RatioIs HIRU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HIRU income statement (TTM) | |
---|---|
Revenue | US$24.04m |
Cost of Revenue | US$15.37m |
Gross Profit | US$8.68m |
Other Expenses | US$5.72m |
Earnings | US$2.95m |
Last Reported Earnings
Dec 31, 2009
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did HIRU perform over the long term?
See historical performance and comparison